Sotera Health (SHC)

Nasdaq Market Closed

Sotera Health Company is a specialised provider of services that support the safety of medical devices, pharmaceuticals, food products, and other regulated goods. The company works with manufacturers that need sterilisation, laboratory testing, and technical consulting to meet quality, regulatory, and product safety requirements before items reach healthcare professionals, patients, and consumers.

Sotera Health operates through three main businesses: Sterigenics, Nordion, and Nelson Labs. Sterigenics is the largest contributor to revenue and provides outsourced terminal sterilisation and irradiation services. Its technologies include gamma irradiation, ethylene oxide processing, and electron beam irradiation, each used for different product types, packaging formats, and sterilisation requirements. These services are especially important for medical devices and healthcare products that cannot be sterilised effectively by manufacturers in-house or by conventional methods.

Nordion supplies products and services connected to gamma technologies, including cobalt-60, a radioisotope widely used in industrial sterilisation. Nelson Labs provides microbiological and analytical testing, helping customers assess sterility, biocompatibility, toxicology, packaging integrity, and other quality attributes. Together, the three segments give Sotera Health a broad role across the product safety chain, from testing and validation to commercial sterilisation.

The company serves customers in the United States, Canada, Europe, and other international markets, with the United States representing its largest geographic source of revenue. Sotera Health’s business is shaped by healthcare production volumes, regulatory standards, outsourcing trends, and demand for safe, sterile products. Its services are typically mission-critical because many medical and pharmaceutical products cannot be distributed without validated sterilisation or testing evidence.

15.57 USD
15.60 USD
+0.30 (+1.96%)
Pre-market

Last updated

Market Cap
4.44B
P/E
37.69
P/FCF
45.85
P/S
3.73
Enterprise Value
6.36B
Sector
Industry
Address
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS, OH, 44147
GlobeNewswire Inc.

Sotera Health Appoints Kenneth D. Krause to the Board of Directors

16 Mar 2026, 15:00 PM
GlobeNewswire Inc.

Sotera Health Announces Secondary Offering of Common Stock

05 Mar 2026, 01:51 AM
GlobeNewswire Inc.

Sotera Health Company Appoints Vincent K. Petrella as Lead Independent Director

07 Jan 2025, 01:30 AM
GlobeNewswire Inc.

Sotera Health to Share Next Chapter of Growth at 2024 Investor Day

20 Nov 2024, 18:00 PM
GlobeNewswire Inc.

Pharmaceutical Sterility Testing Market to Drive Revenue to USD 3.79 Billion by 2032 | CAGR 11.58%

15 Nov 2024, 18:00 PM
GlobeNewswire Inc.

Sotera Health Announces Secondary Offering of Common Stock

05 Sep 2024, 00:41 AM
GlobeNewswire Inc.

Sotera Health Announces Second-Quarter 2024 Earnings Release Date - GlobeNewswire

23 Jul 2024, 01:01 AM
Zacks Investment Research

Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?

25 Jun 2024, 12:33 PM
GlobeNewswire Inc.

Sotera Health Announces Closing of $1.5 Billion Term Loan B and $750 Million Senior Secured Note Financings

31 May 2024, 01:12 AM
Zacks Investment Research

Sotera Health Company (SHC) Misses Q1 Earnings and Revenue Estimates

02 May 2024, 16:35 PM
GlobeNewswire Inc.

Sotera Health Reports First-Quarter 2024 Results

02 May 2024, 15:00 PM
Zacks Investment Research

Sotera Health Company (SHC) Reports Next Week: Wall Street Expects Earnings Growth

25 Apr 2024, 18:01 PM
GlobeNewswire Inc.

Sotera Health Announces First-Quarter 2024 Earnings Release Date

12 Apr 2024, 00:00 AM
GlobeNewswire Inc.

Sotera Health Announces Pricing of Secondary Offering

29 Feb 2024, 03:40 AM
GlobeNewswire Inc.

Sotera Health Announces Secondary Offering of Common Stock

28 Feb 2024, 02:30 AM
Zacks Investment Research

Sotera Health Company (SHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

27 Feb 2024, 18:30 PM
Zacks Investment Research

Sotera Health Company (SHC) Meets Q4 Earnings Estimates

27 Feb 2024, 17:25 PM
GlobeNewswire Inc.

Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook

27 Feb 2024, 16:00 PM
Zacks Investment Research

Unveiling Sotera Health Company (SHC) Q4 Outlook: Wall Street Estimates for Key Metrics

22 Feb 2024, 18:15 PM
Zacks Investment Research

Teladoc (TDOC) Reports Q4 Loss, Misses Revenue Estimates

21 Feb 2024, 02:25 AM
Market Cap
4.44B
Enterprise Value
6.36B
P/E
37.69
P/B
7.13
P/S
3.73
EV / EBITDA
11.11
EV / Sales
5.35
EPS
0.41
Dividend Yield
0%
P/FCF
45.85
P/CF
17
Free Cash Flow
96.84M
ROE
18.92%
ROA
3.64%
Debt / Equity
3.59
Current Ratio
2.81
Quick Ratio
2.53
Cash
1.51
Avg Volume
3.9M
Fundamentals Snapshot Price
15.57

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 280.05M 303.44M 311.31M 294.34M 254.52M
Gross profit 147.07M 165.92M 177.56M 166.62M 135.43M
Operating income 75.83M 170.33M 111.18M 88.43M 26.1M
EBITDA 106.64M 202.85M 139.54M 123.45M 97.85M
Net income 26.59M 34.85M 48.4M 7.96M -13.26M
Basic EPS 0.09 0.12 0.17 0.03 -0.05
Diluted EPS 0.09 0.12 0.17 0.03 -0.05

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 3.24B 3.26B 3.19B 3.22B 3.1B
Total liabilities 2.61B 2.66B 2.64B 2.71B 2.68B
Total equity 622.51M 606.04M 550.47M 511.28M 414.09M
Cash & equivalents 314.15M 344.62M 299.19M 332.44M 304.39M
Current assets 584.17M 611.58M 575.98M 606.34M 553.3M
Current liabilities 207.8M 249.58M 242.4M 246.32M 225.99M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow 29.44M 103.1M 71.15M 57.42M 55.52M
Investing cash flow -45.13M -50.7M -33.34M -31.23M -19.88M
Financing cash flow -12.78M -8.18M -77.34M -6.93M -8.09M
Change in cash -30.51M 45.43M -33.25M 28.19M 27.22M
Kind Filing Date Link
edgar index SD — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
edgar index 3 — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
form 4 Form 4 — SHADER ALTON View Filing
form 4 Form 4 — SHADER ALTON View Filing
form 4 Form 4 — SHADER ALTON View Filing
edgar index 8-K — Sotera Health Co View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — Wheadon David E. View Filing
form 4 Form 4 — Simon, Christopher View Filing
form 4 Form 4 — Chen Ruoxi View Filing
form 4 Form 4 — PETRELLA VINCENT K View Filing
form 4 Form 4 — Neary James View Filing
form 4 Form 4 — Flynn Karen View Filing
form 4 Form 4 — CUNNINGHAM SEAN LAURENCE View Filing
form 4 Form 4 — Krause Kenneth D. View Filing
form 4 Form 4 — Kyle Richard G View Filing
form 4 Form 4 — Klee Ann R. View Filing
edgar index 8-K — Sotera Health Co View Filing
eight k text 8-K — 8-K View Filing
edgar index SCHEDULE 13G — Sotera Health Co View Filing
edgar index SCHEDULE 13G/A — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
edgar index 4 — Sotera Health Co View Filing
edgar index SCHEDULE 13G/A — Sotera Health Co View Filing
edgar index 8-K — Sotera Health Co View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — GTCR FUND XI/A LP View Filing
form 4 Form 4 — GTCR FUND XI/C LP View Filing
form 4 Form 4 — GTCR CO-INVEST XI LP View Filing
form 4 Form 4 — GTCR INVESTMENT XI LLC View Filing
form 4 Form 4 — GTCR PARTNERS XI/A&C LP View Filing
form 4 Form 4 — Warburg Pincus XI Partners, L.P. View Filing
form 4 Form 4 — Bull Co-Invest L.P. View Filing
form 4 Form 4 — Warburg Pincus XI, L.P. View Filing
form 4 Form 4 — Warburg Pincus Private Equity XI-B, L.P. View Filing
form 4 Form 4 — Warburg Pincus Partners II, L.P. View Filing
form 4 Form 4 — Bull Holdco L.P. View Filing
form 4 Form 4 — WP XI Partners, L.P. View Filing
form 4 Form 4 — Warburg Pincus Private Equity XI, L.P. View Filing
form 4 Form 4 — WP Global LLC View Filing
form 4 Form 4 — WARBURG PINCUS & CO. View Filing
form 4 Form 4 — WARBURG PINCUS LLC View Filing
form 4 Form 4 — Warburg Pincus Private Equity XI-C, L.P. View Filing
form 4 Form 4 — Warburg Pincus Partners GP LLC View Filing
form 4 Form 4 — WARBURG PINCUS & CO. View Filing
form 4 Form 4 — Warburg Pincus (Bermuda) Private Equity GP Ltd. View Filing
form 4 Form 4 — Warburg Pincus XI-C, LLC View Filing
form 4 Form 4 — Warburg Pincus Partners II (Cayman), L.P. View Filing
form 4 Form 4 — Warburg Pincus (Cayman) XI, L.P. View Filing
edgar index 424B7 — Sotera Health Co View Filing
edgar index 424B7 — Sotera Health Co View Filing
edgar index DEFA14A — Sotera Health Co View Filing
edgar index 8-K — Sotera Health Co View Filing
edgar index 10-Q — Sotera Health Co View Filing
eight k text 8-K — 8-K View Filing
edgar index DEF 14A — Sotera Health Co View Filing
edgar index DEFA14A — Sotera Health Co View Filing
edgar index ARS — Sotera Health Co View Filing
edgar index 3 — Sotera Health Co View Filing
form 3 Form 3 — Ostrowski Erika View Filing
form 3 Form 3 — Ostrowski Erika View Filing
form 3 Form 3 — Ostrowski Erika View Filing
form 3 Form 3 — Ostrowski Erika View Filing